arrow
J

Jonathan A. Bernstein

University of Cincinnati Medical Center
H指数:106
被引数:5.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence, predictors and psychological conditions of tanning behavioural addiction – A meta-analysis

晒黑行为成瘾的患病率、预测因素及心理状况——一项系统评价

2026-08-290
PRE
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第II部分—口服和眼部治疗指南

2026-03-240
OAAI
The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities

2025年WAO指南:遗传性血管性水肿的分类、诊断和治疗,并考虑全球差异

2026-03-190
OAAI
International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema

遗传性血管性水肿儿童患者诊断与管理国际指南

2026-01-300
OAAI
The International/Canadian hereditary angioedema guideline

国际/加拿大遗传性血管性水肿指南

2026-01-280
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第一部分—关于鼻内治疗的指南

2025-12-010
OAAI
Change, Career Transitions, and Retirement in Allergy-Immunology

变化、职业转型与过敏-免疫学领域的退休

2025-11-260
PRE
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials

罗卡替利单抗治疗中重度特应性皮炎的疗效与安全性:ROCKET-IGNITE和ROCKET-HORIZON两项全球性、双盲、安慰剂对照、随机III期临床研究

2025-11-250
PRE
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms

过敏性鼻炎及其对哮喘的影响(ARIA)-EAACI 2024–2025指南的开发方法:从证据到决策框架到数字化共享决策算法

2025-11-210
OAAI
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
2025-11-150
OAAI
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S

Sebetralstat用于KONFIDENT-S中黏膜遗传性血管性水肿发作的按需治疗

2025-11-010
OAAI